MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
Benjamin Smith(Stanford University), Carolyn R. Bertozzi(Howard Hughes Medical Institute), John V. Pluvinage(University of California, San Francisco), Dean W. Felsher(Stanford Medicine), Anja Deutzmann(Stanford University), Anand Rajan(Johns Hopkins Medicine), Kristina M. Correa(Stanford University), Renumathy Dhanasekaran(Stanford University), Delaney K. Sullivan(California Institute of Technology), Simon Wisnovsky(University of British Columbia), Ravindra Majeti(Stanford University), Corleone S. Delaveris(University of California, San Francisco), Christopher G. Dove(California Institute for Regenerative Medicine), Jessica C. Stark(IIT@MIT), Srividya Swaminathan(City of Hope), Nicholas M. Riley(University of Washington)
Cited by 72
Related Papers
Essentials of Glycobiology
|Unknown|1999|2.5k
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
|Nature Genetics|2016|1.3k
Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945